AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15702199 — intervention group
Group type: COMPARATOR
Intervention: Generalized estimating equations (GEE)
Number of subjects: 0
Study 11714591 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater abstinence-specific structural support (fewer drug users in the social network)
Number of subjects: 128
Study 11714591 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreases in negative abstinence-specific functional support (Complaints about Drug Use, Drug Exposure, and Demoralization)
Number of subjects: 128
Study 11714591 — intervention group
Group type: COMPARATOR
Intervention: General support (structural or functional)
Number of subjects: 128
Study 8993250 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-coated cardiopulmonary bypass surface (Duraflo II)
Number of subjects: 24
Study 8993250 — intervention group
Group type: COMPARATOR
Intervention: Uncoated cardiopulmonary bypass surface
Number of subjects: 24
Study 8181028 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasodilator therapy (hydralazine-isosorbide dinitrate)
Number of subjects: 0
Study 8181028 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0
Study 2955799 — intervention group
Group type: EXPERIMENTAL
Intervention: Orgotein (4 or 8 mg) injected 15 min after each daily radiation treatment
Number of subjects: 30
Study 2955799 — intervention group
Group type: EXPERIMENTAL
Intervention: Orgotein (4 or 8 mg)
Number of subjects: 30
Study 2955799 — intervention group
Group type: COMPARATOR
Intervention: Radiation treatment (63 Gy in 30 fractions)
Number of subjects: 30
Study 29866187 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy protein + flaxseed oil (ISP + FO)
Number of subjects: 73
Study 29866187 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated soy protein + corn oil (ISP + CO)
Number of subjects: 73
Study 29866187 — intervention group
Group type: COMPARATOR
Intervention: Control (wheat flour + corn oil)
Number of subjects: 73
Study 27324534 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HHHFNC)
Number of subjects: 161
Study 27324534 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 161
Study 24307502 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral perioperative antimicrobials (Group I)
Number of subjects: 78
Study 24307502 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended oral antimicrobials for 8 days postoperatively (Group II)
Number of subjects: 78
Study 24307502 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group I)
Number of subjects: 78
Study 22382787 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospium chloride capsule (20 mg, test)
Number of subjects: 20
Study 22382787 — intervention group
Group type: COMPARATOR
Intervention: Trospium chloride tablet (20 mg, reference)
Number of subjects: 20
Study 22382787 — intervention group
Group type: COMPARATOR
Intervention: Comparison of test and reference
Number of subjects: 20
Study 20560981 — intervention group
Group type: EXPERIMENTAL
Intervention: fenofibrate 160 mg daily for 8 weeks
Number of subjects: 14
Study 20560981 — intervention group
Group type: COMPARATOR
Intervention: no treatment for 8 weeks (control)
Number of subjects: 14
Study 17556347 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital fibrinolysis
Number of subjects: 135
Study 17556347 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated PCI
Number of subjects: 135
Study 17556347 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated PCI with TIMI 0‐1
Number of subjects: 135
Study 17556347 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete STR < 70%
Number of subjects: 135
Study 17556347 — intervention group
Group type: EXPERIMENTAL
Intervention: Time‐to‐treatment delay
Number of subjects: 135
Study 16386608 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 15
Study 16386608 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 15
Study 12407040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg oral misoprostol twice daily (days 4-10)
Number of subjects: 150
Study 12407040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 mg vaginal misoprostol and placebo
Number of subjects: 150
Study 12407040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 9674003 — intervention group
Group type: EXPERIMENTAL
Intervention: ketorolac tromethamine 0.5%
Number of subjects: 58
Study 9674003 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac sodium 0.1%
Number of subjects: 58
Study 9674003 — intervention group
Group type: COMPARATOR
Intervention: prednisolone acetate 1%
Number of subjects: 58
Study 7979285 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir 1,000 mg four times daily for 30 days
Number of subjects: 2
Study 7979285 — intervention group
Group type: EXPERIMENTAL
Intervention: Valaciclovir 2,000 mg four times daily for 30 days
Number of subjects: 2
Study 3377946 — intervention group
Group type: COMPARATOR
Intervention: Extradural morphine 3 mg
Number of subjects: 57
Study 3377946 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.18 mg
Number of subjects: 57
Study 3377946 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 0.09 mg
Number of subjects: 57
Study 3377946 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (morphine 3 mg, buprenorphine 0.18 mg, buprenorphine 0.09 mg)
Number of subjects: 57
Study 3377946 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 3 mg and buprenorphine 0.18 mg
Number of subjects: 57
Study 3377946 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 57
Study 31009834 — intervention group
Group type: COMPARATOR
Intervention: Single SUD
Number of subjects: 54
Study 31009834 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly-SUD
Number of subjects: 54
Study 28152251 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton hypofractionated radiotherapy (RT)
Number of subjects: 92
Study 28152251 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion hypofractionated radiotherapy (RT)
Number of subjects: 92
Study 28152251 — intervention group
Group type: COMPARATOR
Intervention: Normal-appearing control tissue
Number of subjects: 92
Study 28152251 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy
Number of subjects: 92
Study 28152251 — intervention group
Group type: EXPERIMENTAL
Intervention: Different PSA thresholds
Number of subjects: 92
Study 28152251 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA relapse criteria according to Vancouver rules
Number of subjects: 92
Study 28152251 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-month measurements
Number of subjects: 92
Study 27520283 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailoring + video-coaching
Number of subjects: 151
Study 27520283 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailoring only
Number of subjects: 151
Study 27520283 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 151
Study 27520283 — intervention group
Group type: COMPARATOR
Intervention: Tailoring + video-coaching vs Waitlist control
Number of subjects: 151
Study 27520283 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 151
Study 24337919 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 850
Study 24337919 — intervention group
Group type: COMPARATOR
Intervention: Fibrinolysis
Number of subjects: 850
Study 24337919 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive therapy (primary PCI)
Number of subjects: 850
Study 23058017 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 AU of LAIS
Number of subjects: 48
Study 23058017 — intervention group
Group type: EXPERIMENTAL
Intervention: 3000 AU of LAIS
Number of subjects: 48
Study 23058017 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study 20008695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 20)
Number of subjects: 36
Study 20008695 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 36
Study 17551699 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg chlorazepate dipotassium (CD) in the evening and 25 mg CD in the morning, placebo 30 min prior to anesthesia
Number of subjects: 50
Study 17551699 — intervention group
Group type: COMPARATOR
Intervention: 7.5 mg midazolam on demand, placebo in the evening
Number of subjects: 50
Study 15543228 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity multilevel intervention (ICAPS)
Number of subjects: 954
Study 11452128 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation of mu-opioid receptor system
Number of subjects: 0
Study 11452128 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous opioids
Number of subjects: 0
Study 9452284 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate suppositories (15 mg/kg/day for three days)
Number of subjects: 52
Study 9452284 — intervention group
Group type: COMPARATOR
Intervention: Oral artesunate (6 mg/kg/day for three days)
Number of subjects: 52
Study 7629484 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole 60 mg day‐1 combined with thyroxine
Number of subjects: 56
Study 7629484 — intervention group
Group type: COMPARATOR
Intervention: Methimazole alone (low-dose)
Number of subjects: 56
Study 7629484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to treat analysis for high-dose group
Number of subjects: 56
Study 7629484 — intervention group
Group type: COMPARATOR
Intervention: Intention to treat analysis for low-dose group
Number of subjects: 56
Study 7629484 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroid volume in relapsed patients
Number of subjects: 56
Study 2774647 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspension-type ointment (0.0056% betamethasone-17-benzoate)
Number of subjects: 31
Study 2774647 — intervention group
Group type: COMPARATOR
Intervention: Solution-type ointment (0.0056% betamethasone-17-benzoate)
Number of subjects: 31
Study 779588 — intervention group
Group type: EXPERIMENTAL
Intervention: Debrisoquine (3 X 10 mg daily)
Number of subjects: 20
Study 779588 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa (3 X 250 mg daily)
Number of subjects: 20
Study 779588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31288016 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR-AA (transcatheter aortic valve replacement via alternative access)
Number of subjects: 81
Study 31288016 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR-TF (transcatheter aortic valve replacement via transfemoral)
Number of subjects: 81
Study 31288016 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR-TF in hybrid OR
Number of subjects: 81
Study 31288016 — intervention group
Group type: COMPARATOR
Intervention: Use of RADPAD (disposable radiation shielding)
Number of subjects: 81
Study 29603656 — intervention group
Group type: EXPERIMENTAL
Intervention: Early guidance
Number of subjects: 33
Study 29603656 — intervention group
Group type: EXPERIMENTAL
Intervention: Late guidance
Number of subjects: 33
Study 29603656 — intervention group
Group type: COMPARATOR
Intervention: No guidance/control
Number of subjects: 33
Study 28838980 — intervention group
Group type: EXPERIMENTAL
Intervention: Fevipiprant 150 mg q.d
Number of subjects: 1058
Study 28838980 — intervention group
Group type: EXPERIMENTAL
Intervention: Fevipiprant 75 mg b.i.d
Number of subjects: 1058
Study 28838980 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg q.d
Number of subjects: 1058
Study 28838980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1058
Study 25797640 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on KI1 (group A)
Number of subjects: 50
Study 25797640 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on DU26 (group B)
Number of subjects: 50
Study 25797640 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on both KI1 and DU26 (group C)
Number of subjects: 50
Study 25797640 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (group D)
Number of subjects: 50
Study 25797640 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture (group E)
Number of subjects: 50
Study 24028643 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 7.5 mg
Number of subjects: 34
Study 24028643 — intervention group
Group type: COMPARATOR
Intervention: Acetazolamide 125 mg
Number of subjects: 34
Study 21426664 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly usage of paclitaxel (45 mg/m², 1 time/week, total 270 mg/m² in 6 weeks)
Number of subjects: 38
Study 21426664 — intervention group
Group type: COMPARATOR
Intervention: Triple weekly usage of paclitaxel (15 mg/m², 3 times/week, total 270 mg/m² in 6 weeks)
Number of subjects: 38
Study 21426664 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 38
Study 20078535 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal incision aortic surgery (MIAS)
Number of subjects: 37
Study 20078535 — intervention group
Group type: COMPARATOR
Intervention: Standard open repair
Number of subjects: 37
Study 17876174 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced decision aid
Number of subjects: 198
Study 17876174 — intervention group
Group type: COMPARATOR
Intervention: Usual Care decision aid
Number of subjects: 198
Study 17876174 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced decision aid (previous digital rectal examination)
Number of subjects: 198
Study 17876174 — intervention group
Group type: COMPARATOR
Intervention: Usual Care decision aid (previous digital rectal examination)
Number of subjects: 198
Study 14725515 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine with 0.0002% fentanyl
Number of subjects: 60
Study 14725515 — intervention group
Group type: COMPARATOR
Intervention: 0.1% levobupivacaine with 0.0002% fentanyl
Number of subjects: 60
Study 11208880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery alone
Number of subjects: 1259
Study 11208880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and chemotherapy
Number of subjects: 1259
Study 11208880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and tamoxifen
Number of subjects: 1259
Study 11208880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery, tamoxifen, and chemotherapy
Number of subjects: 1259
Study 11208880 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 1259
Study 9692100 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal nasal oxygen for 1 week
Number of subjects: 20
Study 9692100 — intervention group
Group type: COMPARATOR
Intervention: Nocturnal room air for 1 week
Number of subjects: 20
Study 9692100 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal nasal oxygen
Number of subjects: 20
Study 1515565 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg per os
Number of subjects: 12
Study 1515565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6540930 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone
Number of subjects: 36
Study 6540930 — intervention group
Group type: COMPARATOR
Intervention: Conventional palliative regimen without corticoid therapy
Number of subjects: 36
Study 30809728 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic technique
Number of subjects: 156
Study 30809728 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic technique
Number of subjects: 156
Study 30152275 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVIGATE
Number of subjects: 404
Study 30152275 — intervention group
Group type: COMPARATOR
Intervention: Usual community care
Number of subjects: 404
Study 26790405 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute inspiratory muscle loading at 60% of maximal inspiratory pressure (PImax)
Number of subjects: 14
Study 26790405 — intervention group
Group type: COMPARATOR
Intervention: Acute inspiratory muscle loading at 2% of maximal inspiratory pressure (PImax, placebo load)
Number of subjects: 14
Study 23612677 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN + preOp
Number of subjects: 75
Study 23612677 — intervention group
Group type: COMPARATOR
Intervention: NIL
Number of subjects: 75
Study 23612677 — intervention group
Group type: EXPERIMENTAL
Intervention: TPN
Number of subjects: 75
Study 21935438 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made notched music training (TMNMT) for patients with tinnitus frequencies ≤8 kHz
Number of subjects: 20
Study 21935438 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made notched music training (TMNMT) for patients with tinnitus frequencies >8 kHz
Number of subjects: 20
Study 21935438 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor-made notched music training (TMNMT)
Number of subjects: 20
Study 19597011 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal and infant antiretroviral therapy, elective cesarean section, avoidance of breast-feeding
Number of subjects: 0
Study 19597011 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother-to-child transmission coverage rates for HIV-positive women
Number of subjects: 0
Study 19597011 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmet need for antiretroviral therapy
Number of subjects: 0
Study 18172379 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle social marketing programme
Number of subjects: 823
Study 18172379 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 823
Study 14694459 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture reflexotherapy
Number of subjects: 42
Study 14694459 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 42
Study 14694459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 11172505 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-injection method (group III) - ulnar nerve not located
Number of subjects: 84
Study 11172505 — intervention group
Group type: COMPARATOR
Intervention: Four-injection method (group IV) - all nerves located
Number of subjects: 84
Study 11172505 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (group III and group IV)
Number of subjects: 84
Study 10985714 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and/or pericardiocentesis for patients with rupture or tamponade (27 out of 28 patients)
Number of subjects: 1048
Study 10985714 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with rupture or tamponade
Number of subjects: 1048
Study 10985714 — intervention group
Group type: COMPARATOR
Intervention: Overall shock cohort
Number of subjects: 1048
Study 7656626 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-step cold-dry air challenge (CACh)
Number of subjects: 128
Study 7656626 — intervention group
Group type: COMPARATOR
Intervention: Histamine challenge
Number of subjects: 128
Study 7656626 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between CACh and histamine challenge
Number of subjects: 128
Study 2562472 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 7
Study 2562472 — intervention group
Group type: EXPERIMENTAL
Intervention: Enprofylline
Number of subjects: 7
Study 2562472 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 7
Study 875803 — intervention group
Group type: EXPERIMENTAL
Intervention: New absorbent bed pad (Kylie)
Number of subjects: 0
Study 875803 — intervention group
Group type: COMPARATOR
Intervention: Drawsheets
Number of subjects: 0
Study 31309977 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week exercise intervention (aerobic and resistance exercise 3 times per week)
Number of subjects: 100
Study 31309977 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 100
Study 28089080 — intervention group
Group type: EXPERIMENTAL
Intervention: Salba‐chia (30 g/1000 kcal/day)
Number of subjects: 77
Study 28089080 — intervention group
Group type: COMPARATOR
Intervention: Oat bran-based control (36 g/1000 kcal/day)
Number of subjects: 77
Study 25545441 — intervention group
Group type: EXPERIMENTAL
Intervention: One corticosteroid course
Number of subjects: 1652
Study 25545441 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat corticosteroid course
Number of subjects: 1652
Study 23190213 — intervention group
Group type: EXPERIMENTAL
Intervention: Indie rock scenes
Number of subjects: 1781
Study 23190213 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic dance music scenes
Number of subjects: 1781
Study 23190213 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesbian parties
Number of subjects: 1781
Study 23190213 — intervention group
Group type: EXPERIMENTAL
Intervention: Alt scenes
Number of subjects: 1781
Study 23190213 — intervention group
Group type: COMPARATOR
Intervention: Hip-hop scenes
Number of subjects: 1781
Study 21269346 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly Unna boot therapy
Number of subjects: 10
Study 19298724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Platelet Component (MPC) measurement in patients with CAD
Number of subjects: 324
Study 16810752 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic resection using a ligation device
Number of subjects: 15
Study 16810752 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic resection
Number of subjects: 15
Study 14687806 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 34
Study 14687806 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 34
Study 14687806 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg
Number of subjects: 34
Study 14687806 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 34
Study 14687806 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 34
Study 10705939 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral parietotemporal hypoperfusion in patients with severe AD, early onset symptoms, and men.
Number of subjects: 220
Study 10705939 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral parietotemporal hypoperfusion in patients with early onset symptoms.
Number of subjects: 220
Study 10705939 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral parietotemporal hypoperfusion in male patients.
Number of subjects: 220